Press Releases from NEUWAY Pharma GmbH (4 total)
NEUWAY Pharma GmbH Names Dr. Oliver Ernst Managing Director, Chief Operating Off …
Bonn, February 25, 2019 - NEUWAY Pharma announced today the appointment of Dr. Oliver Ernst as Managing Director and Chief Operating Officer. Dr. Ernst brings many years of experience in the management of intellectual property rights (IP) in the area of software-based medical technology, pharmaceuticals, and biotechnology, as well as the development of a sustainable, business-related IP strategy. Dr. Ernst previously worked in one of…
NEUWAY Receives €2.95 Million BMBF Grant for Advancing CNS Drug Delivery Platf …
• Grant secures execution of work packages necessary to further validate NEUWAY`s central nervous system (CNS) Drug Delivery Platform for a diverse set of active pharmaceutical substances
• Grant also allows NEUWAY to set-up good manufacturing practice (GMP) production and preparing clinical Phase I study
Bonn, June 07, 2016 - NEUWAY Pharma GmbH, a biopharmaceutical company developing drugs for the treatment of severe orphan CNS diseases, announced today the successful acquisition of non-dilutive funding…
NEUWAY Pharma Extends First Round Financing to € 5.85 Million
Bonn, October 22, 2015 - NEUWAY Pharma announced today the successful closing of a € 3.15 Mio Series A Extension financing round to a total of € 5.85 Million. The lead investor Wellington Partners provided € 2.0 Million of the acquired funds. Life Science Inkubator, Kreditanstalt für Wiederaufbau (KfW) and several private shareholders also participated in the financing round.
Besides the development of the proprietary CNS drug delivery platform, the financial…
NEUWAY Pharma GmbH appoints Dr. Rudi Scherhag as Managing Director
Bonn, August 18, 2015 - NEUWAY Pharma announced today the appointment of Dr. Rudi Scherhag as Chief Operating Officer and Managing Director. Dr. Scherhag has extensive experience in managing various development projects from pre-clinical to registration in the pharmaceutical and biotech industry.
As planned, Dr. Scherhag will take over the managing director position from Dr. Stephan Rapp, who will focus on new projects and act as consultant and shareholder of NEUWAY.
Dr.…
